Sh. Navrattan Munjal, Chairman & Managing Director of IND-SWIFT LABORATORIES LTD. has been conferred with the "IDMA N.I. GANDHI - CHIEF MENTOR AWARD" by the Indian Drug Manufacturers' Association (IDMA), at their 62nd Annual Day Celebration, in recognition and appreciation of his outstanding contribution to the IDMA and the Indian Pharma Industry and for his consistent and unstinted support in meeting the objectives of the IDMA. Sh. Navrattan Munjal had been the National President of the IDMA during 2009-2011.
The Indian Drug Manufacturers' Association (IDMA), established in 1961, is the industry association of leading pharmaceutical companies based out of India. IDMA works with the Government of India on the industry's development plans, represents the industry on prominent issues such as pricing, regulatory affairs, and other policy matters. It also plays a crucial role in keeping business leaders, media, and the public informed about the industry.
Shares of Ind-Swift Laboratories Limited was last trading in BSE at Rs. 112.05 as compared to the previous close of Rs. 112.25. The total number of shares traded during the day was 44786 in over 865 trades.
The stock hit an intraday high of Rs. 118.80 and intraday low of 111.55. The net turnover during the day was Rs. 5161573.00.